These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37307213)

  • 1. Retrospective characterization of nodal marginal zone lymphoma.
    Stuver R; Drill E; Qualls D; Okwali M; Lee Batlevi C; Caron PC; Dogan A; Epstein-Peterson ZD; Falchi L; Hamlin PA; Horwitz SM; Imber BS; Intlekofer AM; Johnson WT; Khan N; Kumar A; Lahoud OB; Lue JK; Matasar MJ; Moskowitz AJ; Noy A; Owens CN; Palomba ML; Schöder H; Vardhana SA; Yahalom J; Zelenetz AD; Salles G; Straus DJ
    Blood Adv; 2023 Sep; 7(17):4838-4847. PubMed ID: 37307213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nodal marginal zone B-cell lymphoma: Analysis of 36 cases. Clinical presentation and treatment outcomes of nodal marginal zone B-cell lymphoma.
    Oh SY; Ryoo BY; Kim WS; Kim K; Lee J; Kim HJ; Kwon JM; Lee HR; Ko YH; Oh SJ; Park KW; Kim HJ; Kwon HC; Nam E; Kim JH; Park YH; Lee SS; Kim HY; Park K
    Ann Hematol; 2006 Nov; 85(11):781-6. PubMed ID: 16847665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual institution experience of nodal marginal zone lymphoma reveals excellent long-term outcomes in the rituximab era.
    Starr AG; Caimi PF; Fu P; Massoud MR; Meyerson H; Hsi ED; Mansur DB; Cherian S; Cooper BW; De Lima MJ; Lazarus HM; Gerson SL; Jagadeesh D; Smith MR; Dean RM; Pohlman BL; Hill BT; William BM
    Br J Haematol; 2016 Oct; 175(2):275-280. PubMed ID: 27443247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric nodal marginal zone lymphoma may develop in the adult population.
    Gitelson E; Al-Saleem T; Robu V; Millenson MM; Smith MR
    Leuk Lymphoma; 2010 Jan; 51(1):89-94. PubMed ID: 19863176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characteristics, Treatment and Evolution of Splenic and Nodal Marginal Zone Lymphomas-Retrospective and Multicentric Analysis of Portuguese Centers.
    Rodrigues CD; Peixeiro RP; Viegas D; Chorão P; Couto ME; Gaspar CL; Fernandes JP; Alves D; Ribeiro LA; de Vasconcelos M P; Tomé AL; Badior M; Coelho H; Príncipe F; Chacim S; da Silva MG; Coutinho R
    Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):e839-e844. PubMed ID: 34326035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nodal marginal zone lymphoma: Clinical features, diagnosis, management and treatment.
    Tadmor T; Polliack A
    Best Pract Res Clin Haematol; 2017; 30(1-2):92-98. PubMed ID: 28288722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO.
    Avivi I; Arcaini L; Ferretti VV; Boumendil A; Finel H; Milone G; Zaja F; Liliana D; Musso M; Didier B; Bachy E; Wattad M; Nicolas-Virelizier E; Gramatzki M; Bourhis JH; Caillot D; Haenel A; Held G; Thieblemont C; Jindra P; Pohlreich D; Guilhot F; Kroschinsky F; Wahlin B; Scheid C; Ifrah N; Berthou C; Dreger P; Montoto S; Conconi A
    Br J Haematol; 2018 Sep; 182(6):807-815. PubMed ID: 29984825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transformation of CD5-positive nodal marginal zone lymphoma to diffuse large B-cell lymphoma].
    Koike T; Iriyama N; Nakagawa M; Takahashi H; Hamada T; Uchino Y; Miura K; Hatta Y; Nakayama T; Takei M
    Rinsho Ketsueki; 2020; 61(3):245-250. PubMed ID: 32224585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of patients with nodal marginal zone lymphoma compared to follicular lymphoma: similar presentation, but differences in prognostic factors and rate of transformation.
    van den Brand M; van der Velden WJ; Diets IJ; Ector GI; de Haan AF; Stevens WB; Hebeda KM; Groenen PJ; van Krieken HJ
    Leuk Lymphoma; 2016 Jul; 57(7):1649-56. PubMed ID: 26694256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canine nodal marginal zone lymphoma: Descriptive insight into the biological behaviour.
    Cozzi M; Marconato L; Martini V; Aresu L; Riondato F; Rossi F; Stefanello D; Comazzi S
    Vet Comp Oncol; 2018 Jun; 16(2):246-252. PubMed ID: 29205839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bendamustine plus rituximab regimen is active against primary nodal marginal zone B-cell lymphoma.
    Laribi K; Tempescul A; Ghnaya H; Denizon N; Besançon A; Anghel A; Farhi J; Truong C; Lemaire P; Poulain S; Bolle D; Ianotto JC; Baugier de Materre A
    Hematol Oncol; 2017 Dec; 35(4):536-541. PubMed ID: 27443419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparate survival outcomes after front-line chemoimmunotherapy in older patients with follicular, nodal marginal zone and small lymphocytic lymphoma.
    Olszewski AJ; Shafqat H; Ali S
    Leuk Lymphoma; 2015 Apr; 56(4):942-50. PubMed ID: 24956144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients.
    Morigi A; Argnani L; Lolli G; Broccoli A; Pellegrini C; Nanni L; Stefoni V; Coppola PE; Carella M; Casadei B; Sabattini E; Cavo M; Zinzani PL
    Hematol Oncol; 2020 Oct; 38(4):487-492. PubMed ID: 32594531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of Upfront Therapy for Marginal Zone Lymphoma.
    Ortega JL; Cabanillas F; Rivera N; Tirado-Gomez M; Hallman D; Pardo WI; Bruno M
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):879-883. PubMed ID: 29042174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodal marginal zone lymphoma.
    Angelopoulou MK; Kalpadakis C; Pangalis GA; Kyrtsonis MC; Vassilakopoulos TP
    Leuk Lymphoma; 2014 Jun; 55(6):1240-50. PubMed ID: 24004184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination.
    Arcaini L; Burcheri S; Rossi A; Passamonti F; Paulli M; Boveri E; Brusamolino E; Orlandi E; Molteni A; Pulsoni A; Cox MC; Orsucci L; Fabbri A; Frezzato M; Voso MT; Zaja F; Montanari F; Pascutto C; Morra E; Cortelazzo S; Lazzarino M
    Oncologist; 2006 Mar; 11(3):285-91. PubMed ID: 16549813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary management of nodal and primary splenic marginal zone lymphoma.
    Leslie LA; Feldman TA; McNeill A; Timberg M; Iida H; Goy AH
    Expert Rev Hematol; 2019 Dec; 12(12):1011-1022. PubMed ID: 31619091
    [No Abstract]   [Full Text] [Related]  

  • 19. Children and adolescents with marginal zone lymphoma have an excellent prognosis with limited chemotherapy or a watch-and-wait strategy after complete resection.
    Ronceray L; Abla O; Barzilai-Birenboim S; Bomken S; Chiang AK; Jazbec J; Kabickova E; Lazic J; Beishuizen A; Mellgren K; Tanaka F; Pillon M; Devalck C; Gouttenoire M; Makarova O; Burkhardt B; Attarbaschi A;
    Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nodal marginal zone B-cell lymphoma: a clinicopathologic study of 10 cases].
    Zhang YN; Zhou XG; Zhang SH; Zheng YY; Liu WH
    Zhonghua Bing Li Xue Za Zhi; 2007 Aug; 36(8):529-33. PubMed ID: 17980100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.